Thrombosis Research, 1879-2472

Tidskrift

Fler filtreringsmöjligheter
  1. 2012
  2. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

    Signy Sveinsdottir, Ymir Saemundsson, Nazim Isma, Anders Gottsäter & Peter Svensson, 2012, I: Thrombosis Research. 130, 3, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. TFPI gene variation and ischemic stroke

    Annie Pedersen, Ellen Hanson, Sandra Olsson, Tara M. Stanne, Christian Blomstrand, Olle Melander, Arne Lindgren, Katarina Jood & Christina Jern, 2012, I: Thrombosis Research. 130, 3, s. 565-567

    Forskningsoutput: TidskriftsbidragLetter

  4. The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives

    K. Bremme, R. Rafik Hamad, Elisabeth Berg, Karin Strandberg & Johan Stenflo, 2012, I: Thrombosis Research. 130, 4, s. 636-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism.

    Alaa Alhadad, Massimo Miniati, Hussein Alhadad, Anders Gottsäter & Marika Bajc, 2012, I: Thrombosis Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2011
  7. Immune tolerance induction in patients with hemophilia A

    Jan Astermark, 2011, I: Thrombosis Research. 127, s. S6-S9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

    Gregory Y. H. Lip, Lars H. Rasmussen, Bertil Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Ulf Eriksson & Karin Wahlander, 2011, I: Thrombosis Research. 127, 2, s. 91-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2010
  10. A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department.

    Jenny M Norlin, Johan Elf, Peter Svensson & Katarina Steen Carlsson, 2010, I: Thrombosis Research. Jul 1, s. 195-199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Anti-prothrombin antibodies are associated with thrombosis in children.

    Olof Rask, Andreas Hillarp, Erik Berntorp & Rolf Ljung, 2010, I: Thrombosis Research. 125, s. 19-24

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Coagulation activation and ultrasound characteristics in patients with carotid artery disease.

    Tilo Kölbel, Isabel Goncalves, Nuno Dias, Karin Strandberg, Stefan Acosta & Anders Gottsäter, 2010, I: Thrombosis Research. 125, s. 171-177

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. History of rFVIIa therapy.

    Ulla Hedner, 2010, I: Thrombosis Research. 125 Suppl 1, s. S4-S6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection

    P. A. Anveden, L. Preutz, Åsa Rudin, Per Flisberg, E. Eldh & Ulf Schött, 2010, I: Thrombosis Research. 125, Suppl. 2, s. S177-S178

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  15. Tissue factor phosphorylation requires protease activated receptor-2 expression: Correlation with the prognosis of human breast cancer

    Lisa Rydén, Dorthe Grabau, F. Schaffner, P. -E. Jonsson, W. Ruf & Mattias Belting, 2010, I: Thrombosis Research. 125, s. S164-S164

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  16. Treatment of the critically ill patient with protein C: Is it worth the cost?

    Gunnar Nilsson, Sören Höjgård & Erik Berntorp, 2010, I: Thrombosis Research. 125, 6, s. 494-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Uncarboxylated matrix Gla-protein (ucMGP) and osteocalcin (ucOC) increase postoperatively after major abdominal cancer and orthopedic surgery

    P. A. Anveden, Attila Frigyesi, L. Schurgers & Ulf Schött, 2010, I: Thrombosis Research. 125, Suppl. 2, s. S178-S178 1 s.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  18. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

    G. Castaman, A. Tosetto, A. Cappelletti, A. Goodeve, A. B. Federici, J. Batlle, D. Meyer, J. Goudemand, J. C. J. Eikenboom, R. Schneppenheim, U. Budde, J. Ingerslev, Stefan Lethagen, F. Hill, I. R. Peake & F. Rodeghiero, 2010, I: Thrombosis Research. 126, 3, s. 227-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2009
  20. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.

    J L Elf, Karin Strandberg, Cecilia Nilsson & P J Svensson, 2009, I: Thrombosis Research. May 29, s. 612-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Haemate P/Humate-P: a systematic review.

    Erik Berntorp, 2009, I: Thrombosis Research. 124 Suppl 1, Nov, s. S11-S14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Increased thrombin generation in women with a history of preeclampsia

    R. Rafik Hamad, J. Curvers, Erik Berntorp, M. J. Eriksson & K. Bremme, 2009, I: Thrombosis Research. 123, 4, s. 580-586

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Thrombin generation after emergency contraception

    M. van Rooijen, Erik Berntorp & K. Bremme, 2009, I: Thrombosis Research. 123, s. S152-S152

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  24. 2008
  25. 2007
  26. Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.

    Karl Malm, Björn Arnljots, Ing-Marie Persson & Björn Dahlbäck, 2007, I: Thrombosis Research. 120, 4, s. 531-539

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers

    Majid Kalani, Angela Silveira, Margareta Blomback, Jan Apelqvist, Bjorn Eliasson, Jan W. Eriksson, Bengt Fagrell, Ole Torffvit, Anders Hamsten & Gun Jorneskog, 2007, I: Thrombosis Research. 120, 5, s. 653-661

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Erik von Willebrand.

    Erik Berntorp, 2007, I: Thrombosis Research. 120, s. S3-S4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. The APC-PCI complex concentration predicts outcome of aortic surgery.

    Gunnar Nilsson, Karin Strandberg, Jan Astermark, Einar Vernersson, Johan Stenflo & Erik Berntorp, 2007, I: Thrombosis Research. 120, s. 237-244

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Von Willebrand: The scientist, the disease, the factor, and the treatment

    Erik Berntorp & David Lillicrap, 2007, I: Thrombosis Research. 120, s. S1-S1

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  31. 2006
  32. Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.

    Pallonji Bhiladvala, Karin Strandberg, Johan Stenflo & Johan Holm, 2006, I: Thrombosis Research. 118, Aug 10, s. 213-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. The need for prophylaxis in von Willebrand's disease and other coagulation disorders

    A Street & Erik Berntorp, 2006, I: Thrombosis Research. 118, s. S1-S2

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  34. The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.

    Erik Berntorp & Thomas Abshire, 2006, I: Thrombosis Research. 18, s. S19-S22

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2005
  36. 2004
  37. Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome.

    Ann-Kristin Öhlin, Johan Holm & Andreas Hillarp, 2004, I: Thrombosis Research. 113, 5, s. 319-326

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2003
  39. Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.

    Andreas Hillarp, Barbro Palmqvist, Stefan Lethagen, Bruno O Villoutreix & Ingrid Mattiasson, 2003, I: Thrombosis Research. 112, 5-6, s. 275-283

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2002
  41. Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

    K Wahlander, L Lapidus, Carl-Gustav Olsson, A Thuresson, UG Eriksson, G Larson & H Eriksson, 2002, I: Thrombosis Research. 107, 3-4, s. 93-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. 2001
  43. Anti- and procoagulant activities in factor VII-deficient subjects

    Jan Astermark, L Tengborn, Ulla Hedner & Erik Berntorp, 2001, I: Thrombosis Research. 101, 6, s. 435-440

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 2000
  45. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters

    Anna Jerkeman, Jan Astermark, Ulla Hedner, Stefan Lethagen, Carl-Gustav Olsson & Erik Berntorp, 2000, I: Thrombosis Research. 98, 6, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 1999
  47. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin

    Johan Holm, Andreas Hillarp, Leif RW Erhardt & Erik Berntorp, 1999, I: Thrombosis Research. 96, 3, s. 205-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. 1997
  49. Activated protein C resistance caused by a common factor V mutation has a single origin

    Bengt Zöller, Andreas Hillarp & Björn Dahlbäck, 1997 feb 1, I: Thrombosis Research. 85, 3, s. 237-43 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man

    Jan Holst, Bengt Lindblad, David Bergqvist, Ulla Hedner, Ole Nordfang & Per Ostergaard, 1997, I: Thrombosis Research. 86, 4, s. 343-348

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 1996
  52. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor

    Jan Holst, Bengt Lindblad, Gertie Westerlund, Claus Bregengaard, Mirella Ezban, Per B. ØStergaard, Ole Nordfang & Ulla Hedner, 1996 feb 15, I: Thrombosis Research. 81, 4, s. 461-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Catabolism of prothrombin-chylomicron complexes in vivo in the rat

    Ning Xu, Li Zhou, Ann-Kristin Öhlin & Åke Nilsson, 1996 jan 15, I: Thrombosis Research. 81, 2, s. 203-212 8822135.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift